The relevant investigative protocol and/or patient note may be attached to your patient's printed or electronic result.

The range of investigative protocols cover conditions associated with:
Clinical Conditions
Abbreviation IP Title
Abnormal Pap Smear Management of abnormal Pap smear results
Female Evaluation of ? androgen excess and/or hirsutism (females)
Female 1 Evaluation of female infertility
Female 2 Evaluation of irregular periods
Female 3 Hormonal changes during menstrual cycle (overlaid)
Female 4 Hormonal changes during menstrual cycle (separate)
HPV What is Human Papilloma Virus?
Prl High Causes of hyperprolactinaemia (prolactin > 700 mIU/L)
Coagulation Tests
Abbreviation IP Title
Platelet Platelet function analysis
Thrombosis Risk factors for venous thromboembolism
vWF1 von Willebrand disease
Drug Screen Interpretation
Abbreviation IP Title
Methadone Evaluation of EDDP (methadone metabolite) results
THC Evaluation of 9-tetrahydrocannabinol (THC) results
UDS Urine drug screening
UDS Amph Evalution of sympathomimetic amine results
UDS Benzo Evaluation of benzodiazepine results
UDS Cocaine Evaluation of cocaine results
UDS Opiate Evaluation of opiate results
Endocrine Tests
Abbreviation IP Title
TSH High Evaluation of an elevated serum TSH (> 4.0 mU/L)
TSH Low Evaluation of a subnormal serum TSH (< 0.2 mU/L)
Vit B12 Investigation of low vitamin B12
General Biochemistry
Abbreviation IP Title
Bicarb High Flowchart for assessment of high plasma bicarbonate
Bicarb Low Causes of low plasma bicarbonate (bicarbonate < 18)
Calcium High 1 Causes of hypercalcaemia (calcium > 2.6)
Calcium High 2 Evaluation of hypercalcaemia (calcium > 2.6)
Calcium Low Evaluation of hypocalcaemia (calcium < 2.2)
CK High Causes of an elevated CK (M > 200 F > 140)
Diabetes Mellitus Screening for type 2 diabetes mellitus
eGFR Estimated Glomerular Filtration Rate (eGFR)
Globulin High Evaluation of hyperglobulinaemia (globulins > 44)
Glucose Low Evaluation of hypoglycaemia (plasma glucose < 2.8 mmol/L)
Haemochromatosis Venesection for haemochromatosis
LDI Evaluation of Lactate Dehydrogenase Isoenzymes (LDI)
Lipid Lowering Drugs 1 PBS criteria for lipid lowering drugs (not high risk)
Lipid Lowering Drugs 2 PBS criteria for lipid lowering drugs (very high risk)
Mag Low Causes of hypomagnesaemia (magnesium < 0.7mmol/L)
Metabolic Syndrome International Diabetes Federation definition
MI Change Cardiac enzyme changes during myocardial infarction
Phos High Causes of hyperphosphataemia (phosphate > 1.8)
Phos Low Causes of hypophosphataemia (mild 0.5~0.65 mmol/L; severe < 0.4 mmol/L)
Polyuria Evaluation of polyuria (urine volume > 3L/24hrs)
Pot High 1 Causes of hyperkalaemia (potassium > 5.0)
Pot High 2 Evaluation of hyperkalaemia (potassium > 5.0)
Pot Low 1 Causes of hypokalaemia (potassium < 3.0)
Pot Low 2 Evaluation of hypokalaemia (potassium < 3.0)
Proteinuria Screening for proteinuria and Chronic Kidney Disease (CKD)
Sodium High Causes of hypernatraemia (sodium > 150)
Sodium Low Causes of hyponatraemia (sodium < 130)
Urate High Evaluation of hyperuricaemia (M > 0.45 F > 0.40)
Immunology
Abbreviation IP Title
Anti-dsDNA and Anti-ENA Guide to Anti-dsDNA and Anti-ENA testing
Coeliac Coeliac disease investigation
IgA Low Evaluation of selective IgA deficiency
IgM Plasma Cell Dys Evaluation of IgM plasma cell dyscrasias
Plasma Cell Dys Evaluation of plasma cell dyscrasias
Liver Function Tests
Abbreviation IP Title
ALP High 1 Causes of an Isolated serum Alkaline Phosphatase (ALP) elevation (ALP > 180 IU/L)
ALP High 2 Evaluation of ALP elevation (ALP > 180 IU/L)
ALP High 3 Evaluation of an isolated serum ALP elevation ? growth related (age < 19 yrs)
ALP High 4 Serum ALP elevation ? growth related (age < 19 yrs) - see flowchart
ALP High 5 Marked serum ALP elevation (ALP > 700 IU/L age < 5 yrs)
GGT High Causes of an elevated serum Gamma Glutamyl Transferase (GGT) (GGT > 100 U/L)
LD High Evaluation of an elevated serum Lactate Dehydrogenase (LD) (LD > 300 U/L)
LFT 1 Evaluation of a moderate elevation of aminotransferase levels (AST & ALT)
LFT 2 Predominant hepatocellular pathology (ALT or AST > 150 U/L ALP < 200 U/L)
LFT 3 Evaluation of a LFT pattern not typical of liver disease (elevated LD, AST > ALT)
LFT 4 Causes of an isolated hyperbilirubinaemia (bilirubin > 25 mmol/L)
LFT 5 Evaluation of an isolated hyperbilirubinaemia (bilirubin > 30 mmol/L)
LFT 6 Evaluation of jaundice (ALT < 400 U/L ALP > 350 U/L)
LFT 7 Evaluation of jaundice (ALT > 300 U/L ALP < 350 U/L)
LFT 8 Evaluation of localised cholestasis (ALP > 180 U/L ALT < 150 U/L GGT > 100 U/L bilirubin < 50 umol/L)
LFT 9 Evaluation of mixed hepatocellular and cholestatic disease (ALP > 180 U/L GGT > 65 U/L ALT or AST > 150 U/L)
Microbiology & Patient Notes
Abbreviation IP Title
Carbapenem Resistant Enterobacteriaceae A family of gram-negative bacilli that occur naturally in the gastro-intestinal tract.
Chikungunya virus & Zika viruses Arthropod-borne viruses (arboviruses) transmitted principally by mosquitoes.
Haematuria Causes of isolated microscopic haematuria
Occult blood Faecal occult blood
Pleural Effusions Pleural effusions - Aetiology, Classification and Tests.
Q Fever Zoonotic disease caused by Coxiella burnetti.
What is Barmah Forest virus? Symptoms, incubation, treatment and prevention of Barmah Forest virus
What is blastocystosis? Symptoms, infection period, diagnosis, treatment and prevention of blastocystosis
What is cryptosporidiosis? Symptoms, infection period, spread of infection and treatment of cryptosporidiosis
What is giardiasis? Symptoms, infection period, spread of infection, diagnosis, treatment and prevention of giardiasis
What is listeriosis? Symptoms, causes, infection period, diagnosis, treatment and prevention of listeriosis
What is parvovirus? Causes, infection period, spread of infection, diagnosis, treatment and prevention of parvovirus
What is Ross River virus? Symptoms, infection period, spread of infection, diagnosis, treatment and prevention of Ross River virus
Serology
Abbreviation IP Title
Hep A Serological events in acute (self-limiting) Hepatitis A infection relative to Alanine Aminotransferase (ALT) peak
Hep B 1 Serological events in acute (self-limiting) Hepatitis B infection relative to ALT peak
Hep B 2 Hepatitis B immune status
HCV Hepatitis C virus (HCV) Medicare criteria
HIV Diagnosis of HIV
HPA Management of Helicobacter pylori infection
Pertussis Treatment of Bordetella pertussis
Q fever Prevaccination Q fever screening
Syphilis Treatment of syphylis
Warfarin Management
Abbreviation IP Title
Warfarin 1 Range of International Normalised Ratio (INR) recommended for specific applications of warfarin therapy
Warfarin 2 Guidelines to the management of an elevated INR, with or without bleeding
Warfarin 3 Risk factors for bleeding complications of warfarin therapy